• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 类 G 蛋白偶联受体的仿生筛选。

Biomimetic screening of class-B G protein-coupled receptors.

机构信息

Max-Planck-Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany.

出版信息

J Am Chem Soc. 2011 Jun 15;133(23):8927-33. doi: 10.1021/ja200160s. Epub 2011 May 23.

DOI:10.1021/ja200160s
PMID:21534574
Abstract

The 41-amino acid peptide corticotropin releasing factor (CRF) is a major modulator of the mammalian stress response. Upon stressful stimuli, it binds to the corticotropin releasing factor receptor 1 (CRF(1)R), a typical member of the class-B G-protein-coupled receptors (GPCRs) and a prime target in the treatment of mood disorders. To chemically probe the molecular interaction of CRF with the transmembrane domain of its cognate receptor, we developed a high-throughput conjugation approach that mimics the natural activation mechanism of class-B GPCRs. An acetylene-tagged peptide library was synthesized and conjugated to an azide-modified high-affinity carrier peptide derived from the CRF C-terminus using copper-catalyzed dipolar cycloaddition. The resulting conjugates reconstituted potent agonists and were tested in situ for activation of the CRF(1) receptor in a cell-based assay. By use of this approach we (i) defined the minimal sequence motif that is required for full receptor activation, (ii) identified the critical functional groups and structure-activity relationships, (iii) developed an optimized, highly modified peptide probe with high potency (EC(50) = 4 nM) that is specific for the activation domain of the receptor, and (iv) probed the behavioral role of CRF receptors in living mice. The membrane recruitment by a high-affinity carrier enhanced the potency of the tethered peptides by >4 orders of magnitude and thus allowed the testing of very weak initial fragments that otherwise would have been inactive on their own. As no chromatography purification of the test peptides was necessary, a substantial increase in screening throughput was achieved. Importantly, the peptide conjugates can be used to probe the endogenous receptor in its native environment in vivo.

摘要

41 个氨基酸组成的肽促肾上腺皮质释放因子(CRF)是哺乳动物应激反应的主要调节剂。在应激刺激下,它与促肾上腺皮质释放因子受体 1(CRF(1)R)结合,后者是典型的 B 类 G 蛋白偶联受体(GPCR)家族成员,也是治疗情绪障碍的主要靶点。为了在化学上探测 CRF 与受体跨膜结构域的分子相互作用,我们开发了一种高通量的缀合方法,该方法模拟了 B 类 GPCR 家族的自然激活机制。合成了一个乙炔标记的肽文库,并使用铜催化的双极性环加成将其与一个来自 CRF C 末端的叠氮修饰的高亲和力载体肽缀合。所得缀合物重建了有效的激动剂,并在基于细胞的测定中就地测试了它们在 CRF(1)受体中的激活作用。通过使用这种方法,我们 (i) 定义了完全激活受体所需的最小序列基序,(ii) 确定了关键的功能基团和结构-活性关系,(iii) 开发了一种优化的、高度修饰的高活性肽探针(EC(50) = 4 nM),该探针对受体的激活结构域具有特异性,(iv) 探测了 CRF 受体在活体小鼠中的行为作用。高亲和力载体的膜募集使连接的肽的效力增强了>4 个数量级,从而允许测试非常弱的初始片段,否则这些片段本身将不活跃。由于不需要对测试肽进行色谱纯化,因此大大提高了筛选通量。重要的是,肽缀合物可用于在体内探测其天然环境中的内源性受体。

相似文献

1
Biomimetic screening of class-B G protein-coupled receptors.B 类 G 蛋白偶联受体的仿生筛选。
J Am Chem Soc. 2011 Jun 15;133(23):8927-33. doi: 10.1021/ja200160s. Epub 2011 May 23.
2
Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.促肾上腺皮质激素释放因子I型受体氨基末端和近膜结构域的配体亲和力:G蛋白和非肽拮抗剂的调节作用
Biochemistry. 2004 Apr 6;43(13):3996-4011. doi: 10.1021/bi036110a.
3
Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.促肾上腺皮质激素释放因子(CRF)受体-配体相互作用中N端结构域的影响。
Biochemistry. 2005 Feb 8;44(5):1614-23. doi: 10.1021/bi049022e.
4
Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.促肾上腺皮质激素释放因子(CRF)2型受体的肽配体结合特性:内源性表达受体的药理学、G蛋白偶联敏感性及CRF2受体选择性的决定因素
Peptides. 2005 Mar;26(3):457-70. doi: 10.1016/j.peptides.2004.10.019.
5
Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.通过修饰激动剂的信号传导结构域实现配体对促肾上腺皮质激素释放因子1型受体的信号传导选择性。
Br J Pharmacol. 2007 Jul;151(6):851-9. doi: 10.1038/sj.bjp.0707293. Epub 2007 May 29.
6
Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.人类和两栖类促肾上腺皮质激素释放因子1型(CRF(1))受体的结合差异:介导高亲和力阿斯特辛结合和功能拮抗作用的氨基酸鉴定
Regul Pept. 2004 May 15;118(3):165-73. doi: 10.1016/j.regpep.2003.12.012.
7
Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.促肾上腺皮质激素释放因子(CRF)家族肽通过CRF受体对大鼠胰腺β细胞中Ca2+内流的调节作用。
Peptides. 2006 Jul;27(7):1814-9. doi: 10.1016/j.peptides.2006.01.011. Epub 2006 Feb 28.
8
Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.尿皮质素II和III的三氨基酸基序决定了它们对促肾上腺皮质激素释放因子受体亚型的选择性。
Neuropharmacology. 2004 Aug;47(2):233-42. doi: 10.1016/j.neuropharm.2004.03.018.
9
A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.单点微小改变被设定为用于绵羊促肾上腺皮质激素释放因子构效关系研究的一种工具。
J Med Chem. 1996 Aug 16;39(17):3324-30. doi: 10.1021/jm960116z.
10
The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.促肾上腺皮质激素释放因子受体N端结构域的三维结构:寿司结构域与G蛋白偶联受体B1家族
Ann N Y Acad Sci. 2006 Jul;1070:105-19. doi: 10.1196/annals.1317.065.

引用本文的文献

1
Chemically Induced Dimerization via Nanobody Binding Facilitates in Situ Ligand Assembly and On-Demand GPCR Activation.通过纳米抗体结合的化学诱导二聚化促进原位配体组装和按需GPCR激活。
JACS Au. 2024 Nov 25;4(12):4780-4789. doi: 10.1021/jacsau.4c00711. eCollection 2024 Dec 23.
2
Improved GPCR ligands from nanobody tethering.通过纳米抗体连接提高 G 蛋白偶联受体配体的亲和力。
Nat Commun. 2020 Apr 29;11(1):2087. doi: 10.1038/s41467-020-15884-8.
3
Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.
促肾上腺皮质素释放因子结合蛋白(CRF-BP)作为阿尔茨海默病和应激障碍的潜在新治疗靶点。
Transl Psychiatry. 2019 Oct 22;9(1):272. doi: 10.1038/s41398-019-0581-8.
4
Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.杨梅素:作为一种天然的B类G蛋白偶联受体激动剂,是治疗2型糖尿病的有效方法。
FASEB J. 2017 Jun;31(6):2603-2611. doi: 10.1096/fj.201601339R. Epub 2017 Mar 7.
5
Conformational states of the full-length glucagon receptor.全长胰高血糖素受体的构象状态
Nat Commun. 2015 Jul 31;6:7859. doi: 10.1038/ncomms8859.
6
Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine.腹侧被盖区中作为可卡因作用靶点的食欲素 - 促肾上腺皮质激素释放因子受体异聚体
J Neurosci. 2015 Apr 29;35(17):6639-53. doi: 10.1523/JNEUROSCI.4364-14.2015.
7
Structure-activity relationships for α-calcitonin gene-related peptide.α-降钙素基因相关肽的构效关系。
Br J Pharmacol. 2013 Dec;170(7):1308-22. doi: 10.1111/bph.12072.
8
The structure and function of the glucagon-like peptide-1 receptor and its ligands.胰高血糖素样肽-1 受体及其配体的结构与功能。
Br J Pharmacol. 2012 May;166(1):27-41. doi: 10.1111/j.1476-5381.2011.01687.x.
9
Receptors: clicking class B GPCR ligands.受体:点击B类G蛋白偶联受体配体。
Nat Chem Biol. 2011 Jul 18;7(8):500-1. doi: 10.1038/nchembio.621.